Acquire the insider country intelligence to execute successful strategies Brazil Pharma Report Last to enter the financial crisis and first to emerge, Brazil has created a new block of middle-class “pharmerging” consumers. Learn key drivers with rapid growth in this ninth-largest market. Report includes key economic data, interviews and company directory. China Pharma Report Favorable government policies towards healthcare and innovation are driving a 20%+ compounded annual growth rate in this market. Learn key drivers with rapid growth in the third-largest worldwide pharmaceutical market. Report includes key economic data and interviews. Ireland Pharma Report In 2012, Ireland enjoyed its best year for foreign direct investment in more than a decade, and its prime minister has promised he'll make it the best small country to do business in by 2016. Have the Irish put their domestic economic crisis behind them? Will boosted infrastructure investment erase industry uncertainty? How will a price-cutting agreement with innovators and generic players change the playing field? Report includes key economic data and interviews. Belgium Pharma Report Despite its small size and lack of natural resources, Belgium is among the most prosperous and competitive countries in the world. The country holds many assets required for the development of a strong knowledge-based economy including an open economy dominated by international functions, the presence of decisive multinational enterprises, the availability of a highly productive and skilled work-force as well as an enviable geostrategic location in Europe. Report includes key economic data and interviews. Expertly maneuver your way through government policies, business regulations and cultural nuances to launch your business in the growth markets of Brazil, China, Ireland and Belgium. Focus Reports serves business professionals in the Pharmaceutical industry. The country reports offer a snapshot of the challenges and issues faced by an industry through the voice and insight of the decision makers at governmental, legislative and corporate levels. They are based on exclusive interviews conducted by our staff.